Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesPreferred Dividend PaymentsProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Traws Pharma (TRAW) Other Operating Expenses (2018 - 2025)

Historic Other Operating Expenses for Traws Pharma (TRAW) over the last 3 years, with Q3 2025 value amounting to -$499000.0.

  • Traws Pharma's Other Operating Expenses rose 4866.26% to -$499000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was -$3.9 million, marking a year-over-year decrease of 10341.78%. This contributed to the annual value of $114.2 million for FY2024, which is 321243.18% up from last year.
  • Per Traws Pharma's latest filing, its Other Operating Expenses stood at -$499000.0 for Q3 2025, which was up 4866.26% from -$545000.0 recorded in Q2 2025.
  • Over the past 5 years, Traws Pharma's Other Operating Expenses peaked at $116.6 million during Q2 2024, and registered a low of -$2.6 million during Q1 2024.